British Research Funding: One Good Cut Deserves Another

Sometimes even your best isn't enough, as some British life science laboratories are finding out, the hard way. Many are scrambling to change priorities and seek other funding to compensate for cuts by the Higher Education Funding Council for England (HEFCE). The council distributes money according to each university's quality rating on the Research Assessment Exercise (RAE), which is based on a seven-point scale (1, 2, 3b, 3a, 4, 5, 5*) with 5* being the highest rating. But even institutions aw

Written byHal Cohen
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

To cushion the blow, HEFCE will taper funding gradually. The University of Greenwich medical department, with an RAE rating of 3a, will receive £1.18 million in cuts. Parliament elevated the former Polytechnic Institute to university status under the Further and Higher Education (Scotland) Act 1992 as part of a national campaign to increase competitiveness. "This decision makes it difficult to nurture new, up-and-coming universities. ...If you strangle research funding at an early stage, what's the chance of developing into a higher grade?" asks Carl Smith, Polytechnic University's press officer. Smith says administrators plan to distribute the cuts so that no one center receives the brunt. "Fortunately we also have other avenues of income to draw from."

The HEFCE funding reductions follow an unprecedented improvement in overall RAE quality ratings and a 10% boost in overall funding that will lift the total life science research budget from £231 million in 2001 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies